We understand that managing your health can be overwhelming at times, but taking these small steps can make a big difference
In contrast, Wegovy has a shorter window of only 28 days at similar temperatures
The STEP UP Trial: Semaglutide Treatment Effect in People with Obesity The trial was a randomized, double-blind phase 3b study of 1,400 adults without type 2 diabetes that investigated a higher dose of Semaglutide (7.2 mg weekly) for weight management in adults with obesity
Side-by-side clinical trial data comparison
In a 26-week study, orforglipron demonstrated a significant dose-dependent effect on weight loss, with weight reduction ranging from 8.6% to 12.6% across various dosages, compared to only 2.0% in the placebo group
Before a patient considers any transition between formulations, they should consult a healthcare professional, he said